Era Mandiri Cemerlang Tbk PT Cash Flow Conversion Efficiency
Era Mandiri Cemerlang Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Era Mandiri Cemerlang Tbk PT (IKAN) has a cash flow conversion efficiency ratio of 0.073x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp5.50 Billion ≈ $322.29K USD) by net assets (Rp75.03 Billion ≈ $4.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Era Mandiri Cemerlang Tbk PT (2017–2024)
Cash flow conversion efficiency of Era Mandiri Cemerlang Tbk PT from 2017 to 2024. This chart illustrates how Era Mandiri Cemerlang Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Era Mandiri Cemerlang Tbk PT share price for real-time trading data and today's change.
Era Mandiri Cemerlang Tbk PT Cash Flow Conversion Ratio Explained
Era Mandiri Cemerlang Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Era Mandiri Cemerlang Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Era Mandiri Cemerlang Tbk PT ranked by their cash flow conversion efficiency. Also see IKAN market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Smooth Rock Ventures Corp
V:SMRV
|
-0.028x |
|
Butn Ltd
AU:BTN
|
0.098x |
|
HiteJinro Holdings Co Ltd
KO:000145
|
-0.021x |
|
Engold Mines Inc
V:EGM
|
-0.201x |
|
Halo Technologies Holdings Ltd
AU:HAL
|
0.345x |
|
Omega Therapeutics Inc
NASDAQ:OMGA
|
-1.214x |
|
STL Global Limited
NSE:SGL
|
-0.005x |
|
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI
|
-1.342x |
Annual Cash Flow Conversion Efficiency for Era Mandiri Cemerlang Tbk PT (2017–2024)
The table below shows the annual cash flow conversion efficiency of Era Mandiri Cemerlang Tbk PT from 2017 to 2024. Review IKAN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp74.50 Billion ≈ $4.37 Million |
Rp-4.60 Billion ≈ $-269.45K |
-0.062x | +24.81% |
| 2023-12-31 | Rp73.69 Billion ≈ $4.32 Million |
Rp-6.05 Billion ≈ $-354.45K |
-0.082x | -178.31% |
| 2022-12-31 | Rp72.76 Billion ≈ $4.26 Million |
Rp7.63 Billion ≈ $446.92K |
0.105x | -7.61% |
| 2021-12-31 | Rp70.72 Billion ≈ $4.14 Million |
Rp8.03 Billion ≈ $470.23K |
0.113x | +119.84% |
| 2020-12-31 | Rp69.13 Billion ≈ $4.05 Million |
Rp-39.55 Billion ≈ $-2.32 Million |
-0.572x | -1589.24% |
| 2019-12-31 | Rp33.57 Billion ≈ $1.97 Million |
Rp1.29 Billion ≈ $75.56K |
0.038x | +104.39% |
| 2018-12-31 | Rp11.88 Billion ≈ $696.08K |
Rp-10.40 Billion ≈ $-609.18K |
-0.875x | -147.20% |
| 2017-12-31 | Rp9.39 Billion ≈ $549.94K |
Rp-3.32 Billion ≈ $-194.70K |
-0.354x | -- |
About Era Mandiri Cemerlang Tbk PT
PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia. It offers mahi-mahi, tuna, swordfish, oilfish, red snapper, grouper, black pomfret, octopus, spanish mackerel, shark, wahoo, goldband snapper, leather jacket, emperor, parrotfish, milkfish, and other fish products. The company also exports its products to the United States, Mexico, Ecuador, German, Holland, Poland, … Read more